Main variables;Fields of operation;Total Units that perform R+D in Biotechnology;Total;1.273 Units that perform R+D in Biotechnology;Units;1.078 Units that perform R+D in Biotechnology;P.A.;126 Units that perform R+D in Biotechnology;Higher Education;59 Units that perform R+D in Biotechnology;PNPI;10 %Units according to biotechnology used: Genetic code;Total;43 %Units according to biotechnology used: Genetic code;Units;35 %Units according to biotechnology used: Genetic code;P.A.;91 %Units according to biotechnology used: Genetic code;Higher Education;93 %Units according to biotechnology used: Genetic code;PNPI;60 %Units according to biotechnology used: Functional units;Total;49 %Units according to biotechnology used: Functional units;Units;42 %Units according to biotechnology used: Functional units;P.A.;89 %Units according to biotechnology used: Functional units;Higher Education;98 %Units according to biotechnology used: Functional units;PNPI;60 %Units according to biotechnology used: Cellular and tissue culturing and engineering;Total;34 %Units according to biotechnology used: Cellular and tissue culturing and engineering;Units;27 %Units according to biotechnology used: Cellular and tissue culturing and engineering;P.A.;68 %Units according to biotechnology used: Cellular and tissue culturing and engineering;Higher Education;90 %Units according to biotechnology used: Cellular and tissue culturing and engineering;PNPI;70 %Units according to biotechnology used: Bioprocesses;Total;51 %Units according to biotechnology used: Bioprocesses;Units;49 %Units according to biotechnology used: Bioprocesses;P.A.;55 %Units according to biotechnology used: Bioprocesses;Higher Education;92 %Units according to biotechnology used: Bioprocesses;PNPI;30 %Units according to biotechnology used: Sub-cellular organisms;Total;16 %Units according to biotechnology used: Sub-cellular organisms;Units;8 %Units according to biotechnology used: Sub-cellular organisms;P.A.;54 %Units according to biotechnology used: Sub-cellular organisms;Higher Education;73 %Units according to biotechnology used: Sub-cellular organisms;PNPI;40 %Units according to biotechnology used: Bio-computing;Total;30 %Units according to biotechnology used: Bio-computing;Units;22 %Units according to biotechnology used: Bio-computing;P.A.;70 %Units according to biotechnology used: Bio-computing;Higher Education;85 %Units according to biotechnology used: Bio-computing;PNPI;20 %Units according to biotechnology used: Nanobiotechnology;Total;19 %Units according to biotechnology used: Nanobiotechnology;Units;14 %Units according to biotechnology used: Nanobiotechnology;P.A.;38 %Units according to biotechnology used: Nanobiotechnology;Higher Education;76 %Units according to biotechnology used: Nanobiotechnology;PNPI;10 %Units according to biotechnology used: Other;Total;12 %Units according to biotechnology used: Other;Units;12 %Units according to biotechnology used: Other;P.A.;11 %Units according to biotechnology used: Other;Higher Education;12 %Units according to biotechnology used: Other;PNPI;10 Units in which biotechnology activities are: Main and/or exclusive;Total;575 Units in which biotechnology activities are: Main and/or exclusive;Units;526 Units in which biotechnology activities are: Main and/or exclusive;P.A.;37 Units in which biotechnology activities are: Main and/or exclusive;Higher Education;3 Units in which biotechnology activities are: Main and/or exclusive;PNPI;9 Units in which biotechnology activities are: A secondary line of business;Total;249 Units in which biotechnology activities are: A secondary line of business;Units;173 Units in which biotechnology activities are: A secondary line of business;P.A.;37 Units in which biotechnology activities are: A secondary line of business;Higher Education;39 Units in which biotechnology activities are: A secondary line of business;PNPI;. Units in which biotechnology activities are: A tool necessary for production;Total;449 Units in which biotechnology activities are: A tool necessary for production;Units;379 Units in which biotechnology activities are: A tool necessary for production;P.A.;52 Units in which biotechnology activities are: A tool necessary for production;Higher Education;17 Units in which biotechnology activities are: A tool necessary for production;PNPI;1 %Units by field(s) of ultimate application of biotechnology use: Human health;Total;54 %Units by field(s) of ultimate application of biotechnology use: Human health;Units;48 %Units by field(s) of ultimate application of biotechnology use: Human health;P.A.;79 %Units by field(s) of ultimate application of biotechnology use: Human health;Higher Education;95 %Units by field(s) of ultimate application of biotechnology use: Human health;PNPI;80 %Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;21 %Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Units;20 %Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;P.A.;16 %Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Higher Education;56 %Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;PNPI;10 %Units by field(s) of ultimate application of biotechnology use: Food products;Total;34 %Units by field(s) of ultimate application of biotechnology use: Food products;Units;33 %Units by field(s) of ultimate application of biotechnology use: Food products;P.A.;22 %Units by field(s) of ultimate application of biotechnology use: Food products;Higher Education;78 %Units by field(s) of ultimate application of biotechnology use: Food products;PNPI;10 %Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Total;26 %Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Units;24 %Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;P.A.;20 %Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Higher Education;68 %Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;PNPI;30 %Units by field(s) of ultimate application of biotechnology use: Environment;Total;18 %Units by field(s) of ultimate application of biotechnology use: Environment;Units;15 %Units by field(s) of ultimate application of biotechnology use: Environment;P.A.;21 %Units by field(s) of ultimate application of biotechnology use: Environment;Higher Education;71 %Units by field(s) of ultimate application of biotechnology use: Environment;PNPI;. %Units by field(s) of ultimate application of biotechnology use: Industry;Total;16 %Units by field(s) of ultimate application of biotechnology use: Industry;Units;14 %Units by field(s) of ultimate application of biotechnology use: Industry;P.A.;13 %Units by field(s) of ultimate application of biotechnology use: Industry;Higher Education;75 %Units by field(s) of ultimate application of biotechnology use: Industry;PNPI;. Personnel in R&D in biotechnology (no. of persons);Total;35.523 Personnel in R&D in biotechnology (no. of persons);Units;10.191 Personnel in R&D in biotechnology (no. of persons);P.A.;12.545 Personnel in R&D in biotechnology (no. of persons);Higher Education;12.512 Personnel in R&D in biotechnology (no. of persons);PNPI;275 Personnel in R&D in biotechnology (no. of persons): Researchers;Total;22.884 Personnel in R&D in biotechnology (no. of persons): Researchers;Units;5.774 Personnel in R&D in biotechnology (no. of persons): Researchers;P.A.;7.135 Personnel in R&D in biotechnology (no. of persons): Researchers;Higher Education;9.744 Personnel in R&D in biotechnology (no. of persons): Researchers;PNPI;231 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;12.639 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Units;4.417 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;P.A.;5.410 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Higher Education;2.768 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;PNPI;44 Personnel in R&D in biotechnology (no. of persons): women;Total;19.474 Personnel in R&D in biotechnology (no. of persons): women;Units;5.525 Personnel in R&D in biotechnology (no. of persons): women;P.A.;7.462 Personnel in R&D in biotechnology (no. of persons): women;Higher Education;6.323 Personnel in R&D in biotechnology (no. of persons): women;PNPI;164 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;11.830 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Units;3.015 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;P.A.;3.974 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Higher Education;4.705 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;PNPI;136 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;7.645 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Units;2.511 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;P.A.;3.488 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Higher Education;1.618 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;PNPI;28 Personnel in R&D in biotechnology (FTE);Total;24.279,7 Personnel in R&D in biotechnology (FTE);Units;7.191,4 Personnel in R&D in biotechnology (FTE);P.A.;9.631,4 Personnel in R&D in biotechnology (FTE);Higher Education;7.374,2 Personnel in R&D in biotechnology (FTE);PNPI;82,7 Personnel in R&D in biotechnology (FTE): Researchers;Total;15.072,1 Personnel in R&D in biotechnology (FTE): Researchers;Units;4.276,6 Personnel in R&D in biotechnology (FTE): Researchers;P.A.;5.063,5 Personnel in R&D in biotechnology (FTE): Researchers;Higher Education;5.675,1 Personnel in R&D in biotechnology (FTE): Researchers;PNPI;56,9 Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;9.207,5 Personnel in R&D in biotechnology (FTE): Technicians and assistants;Units;2.914,7 Personnel in R&D in biotechnology (FTE): Technicians and assistants;P.A.;4.567,9 Personnel in R&D in biotechnology (FTE): Technicians and assistants;Higher Education;1.699,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants;PNPI;25,8 Personnel in R&D in biotechnology (FTE): women;Total;13.704,2 Personnel in R&D in biotechnology (FTE): women;Units;3.985,4 Personnel in R&D in biotechnology (FTE): women;P.A.;5.788,9 Personnel in R&D in biotechnology (FTE): women;Higher Education;3.875,9 Personnel in R&D in biotechnology (FTE): women;PNPI;54 Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;8.019,5 Personnel in R&D in biotechnology (FTE): (women) Researchers;Units;2.234 Personnel in R&D in biotechnology (FTE): (women) Researchers;P.A.;2.874,7 Personnel in R&D in biotechnology (FTE): (women) Researchers;Higher Education;2.873,9 Personnel in R&D in biotechnology (FTE): (women) Researchers;PNPI;36,9 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;5.684,7 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Units;1.751,4 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;P.A.;2.914,2 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Higher Education;1.002 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;PNPI;17,1 Internal expenditure on R&D (thousands of euros);Total;1.540.444 Internal expenditure on R&D (thousands of euros);Units;578.171 Internal expenditure on R&D (thousands of euros);P.A.;578.663 Internal expenditure on R&D (thousands of euros);Higher Education;378.946 Internal expenditure on R&D (thousands of euros);PNPI;4.664 1) By nature of the expense: Current expenses;Total;1.394.144 1) By nature of the expense: Current expenses;Units;517.601 1) By nature of the expense: Current expenses;P.A.;535.547 1) By nature of the expense: Current expenses;Higher Education;336.445 1) By nature of the expense: Current expenses;PNPI;4.552 1.1) Remuneration to researchers;Total;621.703 1.1) Remuneration to researchers;Units;213.755 1.1) Remuneration to researchers;P.A.;196.017 1.1) Remuneration to researchers;Higher Education;210.289 1.1) Remuneration to researchers;PNPI;1.642 1.2) Remuneration to technicians and assistants;Total;272.048 1.2) Remuneration to technicians and assistants;Units;98.440 1.2) Remuneration to technicians and assistants;P.A.;127.585 1.2) Remuneration to technicians and assistants;Higher Education;45.267 1.2) Remuneration to technicians and assistants;PNPI;757 1.3) Other current expenses;Total;500.394 1.3) Other current expenses;Units;205.406 1.3) Other current expenses;P.A.;211.946 1.3) Other current expenses;Higher Education;80.890 1.3) Other current expenses;PNPI;2.153 2) By nature of the expense: Capital expenses;Total;146.299 2) By nature of the expense: Capital expenses;Units;60.570 2) By nature of the expense: Capital expenses;P.A.;43.117 2) By nature of the expense: Capital expenses;Higher Education;42.501 2) By nature of the expense: Capital expenses;PNPI;111 2.1) Land and buildings;Total;38.481 2.1) Land and buildings;Units;22.609 2.1) Land and buildings;P.A.;4.286 2.1) Land and buildings;Higher Education;11.587 2.1) Land and buildings;PNPI;. 2.2) Equipment and instruments;Total;103.079 2.2) Equipment and instruments;Units;36.169 2.2) Equipment and instruments;P.A.;37.163 2.2) Equipment and instruments;Higher Education;29.636 2.2) Equipment and instruments;PNPI;111 2.3) Acquisition of specific R+D software;Total;4.739 2.3) Acquisition of specific R+D software;Units;1.793 2.3) Acquisition of specific R+D software;P.A.;1.668 2.3) Acquisition of specific R+D software;Higher Education;1.278 2.3) Acquisition of specific R+D software;PNPI;. 1) By origin of the funds: National funds;Total;1.367.285 1) By origin of the funds: National funds;Units;487.615 1) By origin of the funds: National funds;P.A.;535.786 1) By origin of the funds: National funds;Higher Education;339.305 1) By origin of the funds: National funds;PNPI;4.579 1.1) Own funds;Total;475.645 1.1) Own funds;Units;330.459 1.1) Own funds;P.A.;78.574 1.1) Own funds;Higher Education;65.797 1.1) Own funds;PNPI;815 1.2) From companies;Total;131.856 1.2) From companies;Units;45.462 1.2) From companies;P.A.;53.216 1.2) From companies;Higher Education;31.579 1.2) From companies;PNPI;1.600 1.3) Public Administration funds;Total;687.638 1.3) Public Administration funds;Units;66.189 1.3) Public Administration funds;P.A.;385.359 1.3) Public Administration funds;Higher Education;234.788 1.3) Public Administration funds;PNPI;1.302 1.4) From Universities;Total;28.830 1.4) From Universities;Units;25.148 1.4) From Universities;P.A.;3.221 1.4) From Universities;Higher Education;423 1.4) From Universities;PNPI;38 1.5) From non profit private institutions;Total;43.316 1.5) From non profit private institutions;Units;20.357 1.5) From non profit private institutions;P.A.;15.416 1.5) From non profit private institutions;Higher Education;6.719 1.5) From non profit private institutions;PNPI;825 1) By origin of the funds: Foreign funds;Total;173.159 1) By origin of the funds: Foreign funds;Units;90.556 1) By origin of the funds: Foreign funds;P.A.;42.878 1) By origin of the funds: Foreign funds;Higher Education;39.640 1) By origin of the funds: Foreign funds;PNPI;84 2.1) From EU programmes;Total;91.809 2.1) From EU programmes;Units;20.932 2.1) From EU programmes;P.A.;36.730 2.1) From EU programmes;Higher Education;34.147 2.1) From EU programmes;PNPI;. 2.2) Other foreign funds;Total;81.350 2.2) Other foreign funds;Units;69.624 2.2) Other foreign funds;P.A.;6.148 2.2) Other foreign funds;Higher Education;5.494 2.2) Other foreign funds;PNPI;84 Purchase of services R & D in Biotechnology to (thousands of euros);Total;197.452 Purchase of services R & D in Biotechnology to (thousands of euros);Units;166.022 Purchase of services R & D in Biotechnology to (thousands of euros);P.A.;30.859 Purchase of services R & D in Biotechnology to (thousands of euros);Higher Education;569 Purchase of services R & D in Biotechnology to (thousands of euros);PNPI;2 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Total;125.047 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Units;97.455 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;P.A.;27.061 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Higher Education;530 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;PNPI;1 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Total;72.404 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Units;68.567 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;P.A.;3.799 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Higher Education;39 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;PNPI;. %Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;48 %Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Units;46 %Units that consider the following obstacles as very important considering biotechnology development: Access to capital;P.A.;60 %Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Higher Education;58 %Units that consider the following obstacles as very important considering biotechnology development: Access to capital;PNPI;60 %Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;13 %Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Units;13 %Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;P.A.;11 %Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Higher Education;12 %Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;PNPI;10 %Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;18 %Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Units;14 %Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;P.A.;41 %Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Higher Education;42 %Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;PNPI;10 %Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;16 %Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Units;14 %Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;P.A.;28 %Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Higher Education;31 %Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;PNPI;10 %Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total;20 %Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Units;17 %Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;P.A.;34 %Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Higher Education;44 %Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;PNPI;30 %Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Total;20 %Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Units;17 %Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;P.A.;34 %Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Higher Education;39 %Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;PNPI;40 %Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total;18 %Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Units;18 %Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;P.A.;14 %Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Higher Education;15 %Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;PNPI;20 %Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;35 %Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Units;35 %Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;P.A.;38 %Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Higher Education;27 %Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;PNPI;10 %Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Total;49 %Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Units;49 %Units that consider the following obstacles as very important considering biotechnology development: Time / cost;P.A.;47 %Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Higher Education;61 %Units that consider the following obstacles as very important considering biotechnology development: Time / cost;PNPI;50 %Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;20 %Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Units;21 %Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;P.A.;20 %Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Higher Education;12 %Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;PNPI;10 %Units that have requested biotechnology patents in Biotechnology;Total;22 %Units that have requested biotechnology patents in Biotechnology;Units;15 %Units that have requested biotechnology patents in Biotechnology;P.A.;51 %Units that have requested biotechnology patents in Biotechnology;Higher Education;75 %Units that have requested biotechnology patents in Biotechnology;PNPI;. Number of patents requested;Total;1.877 Number of patents requested;Units;526 Number of patents requested;P.A.;756 Number of patents requested;Higher Education;595 Number of patents requested;PNPI;.